+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Endometriosis Treatment Market Research Report by Drug Type (GnRH Analogues, LNR-IUDS, and NSAIDs), Treatment Type, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 246 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4989704
UP TO OFF until Dec 31st 2022
The Global Endometriosis Treatment Market size was estimated at USD 2,481.36 million in 2021, USD 2,657.24 million in 2022, and is projected to grow at a CAGR 7.26% to reach USD 3,779.53 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Endometriosis Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Type, the market was studied across GnRH Analogues, LNR-IUDS, NSAIDs, Oral Contraceptives, and Progestins.
  • Based on Treatment Type, the market was studied across Hormonal Therapy and Pain Management.
  • Based on Distribution Channel, the market was studied across E-commerce, Hospital, Pharmacies, and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Endometriosis Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Endometriosis Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Endometriosis Treatment Market, including Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Eli Lilly and Company, Ipsen, Meditrina Pharmaceuticals Private Limited, Myovant Sciences Ltd, Neurocrine Biosciences Inc., Orphagen Pharmaceuticals, Inc., Pfizer Inc., Philogen, and Takeda Pharmaceutical Company.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Endometriosis Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Endometriosis Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Endometriosis Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Endometriosis Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Endometriosis Treatment Market?
6. What is the market share of the leading vendors in the Global Endometriosis Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Endometriosis Treatment Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence rate of endometriosis
5.1.1.2. Increase in the female population within the reproductive age
5.1.1.3. Presence of novel drugs
5.1.2. Restraints
5.1.2.1. Lack of non-invasive diagnostics
5.1.3. Opportunities
5.1.3.1. Rise in research activities for development of new drugs and treatment methodologies
5.1.3.2. Rising use nanotechnology to develop new treatment for endometriosis
5.1.4. Challenges
5.1.4.1. Presence of alternative treatment such as Intrauterine Systems (IUS)
5.2. Cumulative Impact of COVID-19
6. Endometriosis Treatment Market, by Drug Type
6.1. Introduction
6.2. GnRH Analogues
6.3. LNR-IUDS
6.4. NSAIDs
6.5. Oral Contraceptives
6.6. Progestins
7. Endometriosis Treatment Market, by Treatment Type
7.1. Introduction
7.2. Hormonal Therapy
7.3. Pain Management
8. Endometriosis Treatment Market, by Distribution Channel
8.1. Introduction
8.2. E-commerce
8.3. Hospital
8.4. Pharmacies
8.5. Retail Pharmacies
9. Americas Endometriosis Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Endometriosis Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Endometriosis Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. AbbVie Inc.
13.3. Astellas Pharma Inc.
13.4. AstraZeneca PLC
13.5. Bayer AG
13.6. Eli Lilly and Company
13.7. Ipsen
13.8. Meditrina Pharmaceuticals Private Limited
13.9. Myovant Sciences Ltd
13.10. Neurocrine Biosciences Inc.
13.11. Orphagen Pharmaceuticals, Inc.
13.12. Pfizer Inc.
13.13. Philogen
13.14. Takeda Pharmaceutical Company
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL ENDOMETRIOSIS TREATMENT MARKET DYNAMICS
FIGURE 8. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2027
FIGURE 11. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANALOGUES, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANALOGUES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY LNR-IUDS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY LNR-IUDS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (%)
FIGURE 22. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2027
FIGURE 24. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPY, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 29. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 31. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY E-COMMERCE, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 41. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 43. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 49. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2027
FIGURE 51. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 53. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 55. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. MALAYSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. PHILIPPINES ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. SINGAPORE ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. TAIWAN ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 68. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 69. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 70. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 82. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 83. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ENDOMETRIOSIS TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANALOGUES, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANALOGUES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANALOGUES, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANALOGUES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANALOGUES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY LNR-IUDS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY LNR-IUDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY LNR-IUDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY LNR-IUDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY LNR-IUDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 43. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2019-2027 (USD MILLION)
TABLE 44. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY E-COMMERCE, BY STATE, 2019-2027 (USD MILLION)
TABLE 46. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 51. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 56. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 59. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 61. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 66. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 68. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 70. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 71. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 72. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 74. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 75. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 76. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 78. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 79. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 80. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 82. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 83. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 84. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 86. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 87. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 88. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 89. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 92. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 93. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 94. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 96. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 97. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 98. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 100. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 101. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 102. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 104. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 105. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 106. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 108. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 109. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 110. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 112. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 113. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 114. MALAYSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 115. MALAYSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 116. MALAYSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 117. MALAYSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 118. PHILIPPINES ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 119. PHILIPPINES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 120. PHILIPPINES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 121. PHILIPPINES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 122. SINGAPORE ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. SINGAPORE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 124. SINGAPORE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 125. SINGAPORE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 126. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 127. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 128. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 129. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 130. TAIWAN ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 131. TAIWAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 132. TAIWAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 133. TAIWAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 134. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 135. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 136. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 137. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 143. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 144. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 145. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 146. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 147. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 149. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 150. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 151. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 152. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 153. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 154. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 155. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 156. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 157. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 158. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 159. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 160. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 161. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 162. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 163. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 164. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 165. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 166. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 167. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 168. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 169. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 170. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 171. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 172. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 173. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 174. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 175. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 176. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 177. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 178. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 183. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 184. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 185. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 186. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 187. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 188. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 189. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 190. GLOBAL ENDOMETRIOSIS TREATMENT MARKET RANKING
TABLE 191. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 192. GLOBAL ENDOMETRIOSIS TREATMENT MARKET MERGER & ACQUISITION
TABLE 193. GLOBAL ENDOMETRIOSIS TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 194. GLOBAL ENDOMETRIOSIS TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 195. GLOBAL ENDOMETRIOSIS TREATMENT MARKET INVESTMENT & FUNDING
TABLE 196. GLOBAL ENDOMETRIOSIS TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 197. GLOBAL ENDOMETRIOSIS TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Eli Lilly and Company
  • Ipsen
  • Meditrina Pharmaceuticals Private Limited
  • Myovant Sciences Ltd
  • Neurocrine Biosciences Inc.
  • Orphagen Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Philogen
  • Takeda Pharmaceutical Company

Methodology

Loading
LOADING...